только для медицинских специалистов
Консультант врача. Электронная медицинская библиотека

Консультант врача

Электронная медицинская библиотека

Доступ к библиотеке Версия для слабовидящих
Раздел 16 / 16
Страница 1 / 1

Список литературы

  1. Бабияк В.И., Захаренкова О.В., Пащинин А.Н., Воронов В.А. Способ лечения больных с доброкачественным пароксизмальным позиционным головокружением с поражением переднего полукружного канала. Патент на изобретение RU 2487693.
  2. Бабияк В.И., Говорун М.И., Накатис Я.А. Оториноларингология: руководство : в 2 т. Т. 2. Санкт-Петербург : Питер, 2009. 832 с.
  3. Благовещенская Н.С. Отоневрологические симптомы и синдромы. Москва : Медицина, 1990. 432 с.
  4. Бронштейн А., Лемперт Т. Головокружение. Москва : ГЭОТАР-Медиа, 2010. 216 с.
  5. Гайворонский И.В. Нормальная анатомия человека: учебник для медицинских вузов : в 2 т. Т. 2. Санкт-Петербург : СпецЛит, 2007. 424 с.
  6. Гофман В.Р. Современные методы исследования вестибулярного анализатора. Военно-медицинская академия, кафедра оториноларингологии. Лекция для слушателей факультета руководящего медицинского состава. Санкт-Петербург, 2003.
  7. Григорьев Г.М. Нистагм положения. Обзор зарубежной литературы 1950–1961 гг. // Вестник оториноларингологии. 1962. № 5. С. 67–72.
  8. Замерград М.В. Вестибулярное головокружение // Неврология, психиатрия, психосоматика. 2009. № 1. С. 14–18.
  9. Лихачев С.А., Марьенко И.П. Диагностическое и экспертное значение функциональных тестов при выявлении латентной вестибулярной дисфункции // Вестник оториноларингологии. 2008. № 1. С. 24–27.
  10. Лихачев С.А., Плешко И.В. Подавление вестибулоокулярного рефлекса взором у больных с задним шейным симпатическим синдромом // Вестник оториноларингологии. 2009. № 1. С. 12–15.
  11. Национальное руководство по оториноларингологии / под ред. В.Т. Пальчуна. Москва : ГЭОТАР-Медиа, 2008. 960 с.
  12. Солдатов И.Б. Лекции по оториноларингологии. Москва : Медицина, 1994. 288 с.
  13. A 1-year safety study of OTO-104 in subjects with unilateral Ménière’s disease located in United Kingdom. URL: https://clinicaltrials.gov/ct2/show/NCT02265393
  14. AAO-HNS Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière’s disease. American Academy of Otolaryngology — Head and Neck Foundation, Inc. // Otolaryngol. Head Neck Surg. 1995. Vol. 113, N 3. P. 181–185.
  15. Аdrion C., Fischer C.S., Wagner J. et al. Efficacy and safety of betahistine treatment in patients with Ménière’s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial) // BMJ. 2016. Vol. 352. P. h6816.
  16. Alexander G., Barany R. Psychophysiologische Untersuchungen über die Bedeutung des Statolithenapparates für die Orientierung im Räume an Normalen und Taubstummen, nebst Beiträgen zur Orientierung mittels taktiler und optischer Empfindungen // Z. Psychol. 1904. Bd 37. S. 312–362, 414–456.
  17. Arbusow V., Theil D., Strupp M., Mascolo A., Brandt T. HSV-1 not only in human vestibular ganglia but also in the vestibular labyrinth // Audiol. Neurootol. 2001. Vol. 6, N 5. P. 259–262.
  18. Bhattacharyya N., Gubbels S.P., Schwartz S.R., Edlow J.A., El-Kashlan H., Fife T. et al. Clinical practice guideline: benign paroxysmal positional vertigo (update) // Otolaryngol. Head Neck Surg. 2017. Vol. 156, N 3. Suppl. P. S1–S47. DOI: https://doi.org/10.1177/0194599816689667 PMID: 28248609.
  19. Brandt T., Dieterich M., Strupp M. Vertigo — Leitsymptom Schwindel. 2nd ed. Heidelberg : Springer Medizin, 2012.
  20. Burkin A. Betahistine treatment of Ménière’s syndrome // Clin. Med. 1967. Vol. 74. P. 41–48.
  21. Casani A.P., Piaggi P., Cerchiai N. et al. Intratympanic treatment of intractable unilateral Ménière disease: gentamicin or dexamethasone? A randomized controlled trial // Otolaryngol. Head Neck Surg. 2012. Vol. 146. P. 430–437.
  22. Chia S.H., Gamst A.C., Anderson J.P., Harris J.P. Intratympanic gentamicin therapy for Ménière’s disease: a meta-analysis // Otol. Neurotol. 2004. Vol. 25. P. 544–552.
  23. Citek K., Ball B., Rutledge D.A. Nystagmus testing in intoxicated individuals // Optometry. 2003. Vol. 74, N 11. P. 695–710.
  24. Coelho D.H., Lalwani A.K. Medical management of Méniére’s disease // Laryngoscope. 2008. Vol. 118. P. 1099–1008.
  25. Cohen H.S. Side-lying as an alternative to the Dix-Hallpike test of the posterior canal // Otol. Neurotol. 2004. Vol. 25, N 2. P. 130–134.
  26. De La Cruz A., Borne Teufert K., Berliner K. Transmastoid labyrinthectomy versus translabyrinthine vestibular nerve section: does cutting the vestibular nerve make a difference in outcome? // Otol. Neurotol. 2007. Vol. 28. P. 801–808.
  27. Diamond C., O’Connell D.A., Hornig J.D., Liu R. Systematic review of intratympanic gentamicin in Ménière’s disease // J. Otolaryngol. 2003. Vol. 32. P. 351–361.
  28. Diaz R.C., LaRouere M.J., Bojrab D.I. Quality-of-life assessment of Ménière’s disease patients after surgical labyrinthectomy // Otol. Neurotol. 2007. Vol. 28, N 1. P. 74–86.
  29. Dix M.R., Hallpike C.S. The pathology, symptomatology and diagnosis of certain common disorders of the vestibular system // Proc. R. Soc. Med. 1952. Vol. 45, N 6. P. 341–354.
  30. Eggers S.D.Z., Zee D.S. Vertigo and Imbalance: Clinical Neurophysiology of the Vestibular System Handbook of Clinical Neurophysiology. Vol. 9. Elsevier, 2009. 575 p.
  31. Engström M., Berg T., Stjernquist-Desatnik A., Axelsson S., Pitkäranta A., Hultcrantz M. et al. Prednisolone and valaciclovir in Bell’s palsy: a randomised, double-blind, placebo-controlled, multicentre trial // Lancet Neurol. 2008. Vol. 7, N 11. P. 993–1000.
  32. Fiorino F., Pizzini F.B., Beltramello A. et al. Reliability of magnetic resonance imaging performed after intratympanic administration of gadolinium in the identification of endolymphatic hydrops in patients with Ménière’s disease // Otol. Neurotol. 2011. Vol. 32, N 3. P. 472–477.
  33. Fishman J.M., Burgess C., Waddell A. Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) // Cochrane Database Syst. Rev. 2011. Vol. 5. CD008607.
  34. Fitzgerald G., Hallpike C.S. Studies of the human vestibular function. Observations on the directional preponderance («Nystagmusbereitschaft») of caloric nystagmus resulting from central lesions // Brain. 1942. Vol. 65. P. 115–137.
  35. Fleiss J.L. The Design and Analysis of Clinical Experiments. The Crossover Study. Chichester, New York, Brislane, Toronto, Singapore : Wiley, 1986. 432 p.
  36. Friberg U., Stahle J., Svedberg A. The natural course of Ménière’s disease // Acta Otolaryngol. 1984. Vol. 406, suppl. P. 72–77.
  37. Gacek R.R., Gacek M.R. The three faces of vestibular ganglionitis // Ann. Otol. Rhinol. Laryngol. 2002. Vol. 111, N 2. P. 103–114.
  38. Garduno-Anaya M.A., Couthino De T.H., Hinojosa-Gonzalez R., Pane-Pianese C., Rios-Castaneda L.C. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière’s disease: a two-year prospective, placebo-controlled, double-blind, randomized trial // Otolaryngol. Head Neck Surg. 2005. Vol. 133. P. 285–294.
  39. Garduño-Anaya M.A., Couthino De Toledo H., Hinojosa-González R. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière’s disease: a two-year prospective, placebo-controlled, double-blind, randomized trial // Otolaryngol. Head Neck Surg. 2005. Vol. 133. P. 285–294.
  40. Geser R., Straumann D. Referral and final diagnoses of patients assessed in an academic vertigo center // Front. Neurol. 2012. Vol. 3. P. 169.
  41. Gufoni M., Mastrosimone L., Di Nasso F. [Repositioning maneuver in benign paroxysmal vertigo of horizontal semicircular canal] // Acta Otorhinolaryngol. Ital. 1998. Vol. 18, N 6. P. 363–367.
  42. Guneri E.A., Kustutan O. The effects of betahistine in addition to epley maneuver in posterior canal benign paroxysmal positional vertigo // Otolaryngol. Head Neck Surg. 2012. Vol. 146, N 1. P. 104–108.
  43. Gürkov R., Pyykö I., Zou J., Kentala E. What is Ménière’s disease? A contemporary re-evaluation of endolymphatic hydrops // J. Neurol. 2016. Vol. 263, N 1. P. 71–81.
  44. Gürkov R., Flatz W., Louza J. et al. In vivo visualized endolymphatic hydrops and inner ear functions in patients with electrocochleographically confirmed Ménière’s disease // Otol. Neurotol. 2012. Vol. 33. P. 1040–1045.
  45. Gürkov R., Kantner C., Strupp M. Endolymphatic hydrops in patients with vestibular migraine and auditory symptoms // Eur. Arch. Otorhinolaryngol. 2014. Vol. 271. P. 2661–2667.
  46. Gürkov R., Flatz W., Ertl-Wagner B., Krause E. Endolymphatic hydrops in the horizontal semicircular canal: a morphologic correlate for canal paresis in Ménière’s disease // Laryngoscope. 2013. Vol. 123, N 2. P. 503–506.
  47. Gürkov R., Flatz W., Louza J., Strupp M., Krause E. In vivo visualization of endolyphatic hydrops in patients with Ménière’s disease: correlation with audiovestibular function // Eur. Arch. Otorhinolaryngol. 2011. Vol. 268, N 12. P. 1743–1748.
  48. Gürkov R., Flatz W., Louza J. et al. Herniation of the membranous labyrinth into the horizontal semicircular canal is correlated with impaired caloric response in Ménière’s disease // Otol. Neurotol. 2012. Vol. 33, N 8. P. 1375–1379.
  49. Gürkov R., Flatz W., Keeser D. et al. Effect of standard-dose Betahistine on endolymphatic hydrops: an MRI pilot study // Eur. Arch. Otorhinolaryngol. 2013. Vol. 270, N 4. P. 1231–1235.
  50. Hallpike C.S., Cairns H. Observations on the pathology of Ménière’s syndrome // Proc. R. Soc. Med. 1938. Vol. 31. P. 1317–1336.
  51. Hannigan I.P., Welgampola M.S., Watson Shaun R.D. Dissociation of caloric and head impulse tests: a marker of Ménière’s disease // J. Neurol. 2019. Vol. 266, N 12. P. 3162.
  52. Hillier S.L., McDonnell M. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction // Cochrane Database Syst. Rev. 2011. Vol. 2. CD005397.
  53. Hüfner K., Barresi D., Glaser M. et al. Vestibular paroxysmia: diagnostic features and medical treatment // Neurology. 2008. Vol. 71. P. 1006–1014.
  54. Huh Y.E., Kim J.S. Bedside evaluation of dizzy patients // J. Clin. Neurol. 2013. Vol. 9, N 4. P. 203–213.
  55. Huppert D., Strupp M., Brandt T. Long-term course of Ménière’s disease revisited // Acta Otolaryngol. 2010. Vol. 130. P. 644–651.
  56. Huppert D., Strupp M., Rettinger N., Hecht J., Brandt T. Phobic postural vertigo — a long-term follow-up (5 to 15 years) of 106 patients // J. Neurol. 2005. Vol. 252, N 5. P. 564–569.
  57. Jafek B.W., Murrow B.W. ENT Secrets. Elsevier, Mosby, 2005. 466 p.
  58. James A.L., Burton M.J. Betahistine for Menière’s disease or syndrome // The Cochrane Library. 2005. Issue 4.
  59. Jeffcoat B., Shelukhin A., Fong A., Mustain W., Zhou W. Alexander’s law revisited // J. Neurophysiol. 2008. Vol. 100, N 1. P. 154–159.
  60. Jeong S.H., Kim J.S., Shin J.W., Kim S., Lee H., Lee A.Y. et al. Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo // J. Neurol. 2013. Vol. 260, N 3. P. 832–838.
  61. Jerin C., Krause E., Ertl-Wagner B., Gurkov R. Longitudinal assessment of endolymphatic hydrops with contrast-enhanced magnetic resonance imaging of the labyrinth // Otol. Neurotol. 2014. Vol. 35, N 5. P. 880–883.
  62. Karlberg M.L., Magnusson M. Treatment of acute vestibular neuronitis with glucocorticoids // Otol. Neurotol. 2011. Vol. 32. P. 1140–1143.
  63. Kim J.S., Oh S.Y., Lee S.H., Kang J.H., Kim D.U., Jeong S.H. et al. Randomized clinical trial for geotropic horizontal canal benign paroxysmal positional vertigo // Neurology. 2012. Vol. 79, N 7. P. 700–707.
  64. Lempert T. Horizonta benign positional vertigo // Neurology. 1994. Vol. 44. P. 2213–2224.
  65. Lindqvist A., Nyman G. Dizziness: Vertigo, Disequilibrium and Lightheadedness. Nova Publishers, 2009. 241 p.
  66. Longridge N.S., Mallinson A.I. Low-dose intratympanic gentamicin treatment for dizziness in Ménière’s disease // J. Otolaryngol. 2000. Vol. 29. P. 35–39.
  67. Lopez-Escamez J.A., Carey J., Chung W.H. et al. Diagnostic criteria for Ménière’s disease // J. Vestib. Res. 2015. Vol. 25, N 1. P. 1–7.
  68. Louza J., Krause E., Gürkov R. Audiologic evaluation of Ménière’s disease patients one day and one week after intratympanic application of gadolinium contrast agent: our experience in sixty-five patients // Clin. Otolaryngol. 2013. Vol. 38, N 3. P. 262–266.
  69. Louza J., Krause E., Gürkov R. Hearing function after intratympanic application of gadolinium-based contrast agent: a long-term evaluation // Laryngoscope. 2015. Vol. 125, N 10. P. 2366–2370.
  70. Louza J.P., Flatz W., Krause E., Gürkov R. Short-term audiologic effect of intratympanic gadolinium contrast agent application in patients with Ménière’s disease // Am. J. Otolaryngol. 2012. Vol. 33, N 5. P. 533–537.
  71. McCaslin D.L., Rivas A., Jacobson G.P., Bennett M.L. The dissociation of video head impulse test (vHIT) and bithermal caloric test results provide topological localization of vestibular system impairment in patients with «definite» Ménière’s disease // Am. J. Audiol. 2015. Vol. 24, N 1. P. 1–10.
  72. McGarvie L.A., Curthoys I.S., MacDougall H.G., Halmagyi G.M. What does the dissociation between the results of video head impulse versus caloric testing reveal about the vestibular dysfunction in Ménière’s disease? // Acta Otolaryngol. 2015. Vol. 135, N 9. P. 859–865.
  73. Merchant S.N., Rauch S.D., Nadol J.B. Jr. Ménière’s disease // Eur. Arch. Otorhinolaryngol. 1995. Vol. 252, N 2. P. 63–75.
  74. Minor L.B. Intratympanic gentamicin for control of vertigo in Ménière’s disease: vestibular signs that specify completion of therapy // Am. J. Otol. 1999. Vol. 20. P. 209–219.
  75. Mira E., Guidetti G., Ghilardi L. et al. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo // Eur. Arch. Otorhinolaryngol. 2003. Vol. 260. P. 73–77.
  76. Moffat D.A., Ballagh R.H. Ménière’s disease // Scott-Brown’s Otolaryngology. 6th ed. / eds A.G. Kerr, J.B. Booths. Oxford : Butterworth-Heinemann, 1997.
  77. Morel N., Dumas G., Nguyen D.Q., Mohr E. Vestibular neurotomy versus chemical labyrinthectomy for disabling Ménière disease // Ann. Otolaryngol. Chir. Cervicofac. 2005. Vol. 122. P. 271–280.
  78. Morita N., Kariya S., Farajzadeh Deroee A. et al. Membranous labyrinth volumes in normal ears and Ménière disease: a three-dimensional reconstruction study // Laryngoscope. 2009. Vol. 119, N 11. P. 2216–2220.
  79. Murdin L., Hussain K., Schilder A.G. Betahistine for symptoms of vertigo // Cochrane Database Syst. Rev. 2016. Vol. 21. CD010696.
  80. Naganawa S., Yamazaki M., Kawai H. et al. Visualization of endolymphatic hydrops in Ménière’s disease with single-dose intravenous gadolinium-based contrast media using heavily T(2)-weighted 3D-FLAIR // Magn. Reson. Med. Sci. 2010. Vol. 9, N 4. P. 237–242.
  81. Naganawa S., Satake H., Kawamura M. et al. Separate visualization of endolymphatic space, perilymphatic space and bone by a single pulse sequence; 3D-inversion recovery imaging utilizing real reconstruction after intratympanic Gd-DTPA administration at 3 Tesla // Eur. Radiol. 2008. Vol. 18, N 5. P. 920–924.
  82. Naganawa S., Nakashima T. Visualization of endolymphatic hydrops with MR imaging in patients with Ménière’s disease and related pathologies: current status of its methods and clinical significance // Jpn. J. Radiol. 2014. Vol. 32, N 4. P. 191–204.
  83. Nakada T., Yoshida T., Suga K. Endolymphatic space size in patients with vestibular migraine and Ménière’s disease // J. Neurol. 2014. Vol. 261. P. 2019–2084.
  84. Nakashima T., Naganawa S., Pyykko I. et al. Grading of endolymphatic hydrops using magnetic resonance imaging // Acta Otolaryngol. 2009. Vol. 560. P. 5–8.
  85. Nakashima T., Naganawa S., Teranishi M. et al. Endolymphatic hydrops revealed by intravenous gadolinium injection in patients with Ménière’s disease // Acta Otolaryngol. 2010. Vol. 130, N 3. P. 338–343.
  86. Nakashima T., Naganawa S., Sugiura M. et al. Visualization of endolymphatic hydrops in patients with Ménière’s disease // Laryngoscope. 2007. Vol. 117. P. 415–420.
  87. Neuhauser H.K. Epidemiology of vertigo // Curr. Opin. Neurol. 2007. Vol. 20, N 1. P. 40–46.
  88. Newman-Toker D.E., Kattah J.C., Alvernia J.E., Wang D.Z. Normal head impulse test differentiates acute cerebellar strokes from vestibular neuritis // Neurology. 2008. Vol. 70, N 24. Pt 2. P. 2378–2385.
  89. Newman-Toker D.E., Saber Tehrani A.S., Mantokoudis G., Pula J.H., Guede C.I., Kerber K.A. et al. Quantitative video-oculography to help diagnose stroke in acute vertigo and dizziness. Toward an ECG for the eyes // Stroke. 2013. Vol. 44, N 4. P. 1158–1161.
  90. Ng M., Srireddy S., Horlbeck D.M., Niparko J.K. Safety and patient experience with transtympanic electrocochleography // Laryngoscope. 2001. Vol. 111. P. 792–795.
  91. Hussain K, Murdin L., Schilder A.G. Restriction of salt, caffeine and alcohol intake for the treatment of Ménière’s disease or syndrome // Cochrane Database Syst. Rev. 2018. Vol. 12. CD012173.
  92. Nylen C.O. Positional nystagmus. A review and future prospects // J. Laryngol. Otol. 1950. Vol. 64. P. 295–318.
  93. Okamato K., Hazeyama F., Taira T. et al. Therapeutic results of betahistine in Ménière’s disease with statistical analysis // Iryo. 1968. Vol. 22. P. 650–666.
  94. Ozturk K., Ata N. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Ménière’s disease // Am. J. Otolaryngol. 2019. Vol. 40, N 5. P. 711–714.
  95. Postema R.J., Kingma C.M., Wit H.P. Intratympanic gentamicin therapy for control of vertigo in unilateral Ménière’s disease: a prospective, double-blind, randomized, placebo-controlled trial // Acta Otolaryngol. 2008. Vol. 128. P. 876–880.
  96. Pang B., Costeloe A., Jackson N.M., Babu S. Incidence of developing contralateral Ménière’s disease in patients undergoing transmastoid labyrinthectomy for unilateral Ménière’s disease // Ear Nose Throat J. 2021. Vol. 100, N 2. P. 86–89.
  97. Parnes L.S., McClure J.A. Free-floating endolymph particles: a new operative finding during posterior semicircular canal occlusion // Laryngoscope. 1992. Vol. 102, N 9. P. 988–992.
  98. Phillips J.S., Westerberg B. Intratympanic steroids for Ménière’s disease or syndrome // Cochrane Database Syst. Rev. 2011. Vol. 7. CD008514.
  99. Plontke S.K., Gürkov R. Ménière’s disease // Laryngo-Rhino-Otologie. 2015. Vol. 94, N 8. P. 530–554.
  100. Pullens B., Verschuur H.P., van Benthem P.P. Surgery for Ménière’s disease // Cochrane Database Syst. Rev. 2013. Vol. 2. CD005395.
  101. Hussain K, Murdin L., Schilder A.G. Restriction of salt, caffeine and alcohol intake for the treatment of Ménière’s disease or syndrome // Cochrane Database Syst. Rev. 2018. Vol. 12. CD012173.
  102. Hussain K, Murdin L., Schilder A.G. Restriction of salt, caffeine and alcohol intake for the treatment of Ménière’s disease or syndrome // Cochrane Database Syst. Rev. 2018. Vol. 12. CD012173.
  103. Pyykko I., Nakashima T., Yoshida T., Zou J., Naganawa S. Ménière’s disease: a reappraisal supported by a variable latency of symptoms and the MRI visualisation of endolymphatic hydrops // BMJ Open. 2013. Vol. 3, N 2. Article ID e001555.
  104. Pyykko I., Zou J., Poe D. Magnetic resonance imaging of the inner ear in Ménière’s disease // Otolaryngol. Clin. North Am. 2010. Vol. 15. P. 353–363.
  105. Quaranta A., Scaringi A., Aloidi A. et al. Intratympanic therapy for Ménière’s disease: effect of administration of low concentration of gentamicin // Acta Otolaryngol. 2001. Vol. 121. P. 387–392.
  106. Quintart G.K. Etude preliminaire experimentale sur l’incidence des anomalies vasculaires du tronc vertebro-basilaire dans les pathologies dites «vertigineuses» vestibulaires. DIU reeducation fonctionnelle de l’equilibre UFR 067 medecine P.M. Curie. Année académique 2007–2008. 17 p.
  107. Reeves A.G., Swenson R.S. Disorders of the nervous system. Online version developed at Darmouth medical school. Chapter 14. URL: https://www.dartmouth.edu/~dons/index.html
  108. Ricci V., Sittoni V., Nicora M. Efficacy and safety of betahistine hydrochloride versus placebo in Ménière’s disease // Riv. Ital. Ornitolog. Audiolog. Foniat. 1987. Vol. 7. P. 347–350.
  109. Rubin F., Simon F., Verillaud B. et al. Comparison of video head impulse test and caloric re ex test in advanced unilateral de nite Ménière’s disease // Eur. Ann. Otorhinolaryngol. Head Neck Dis. 2018. Vol. 135, N 3. P. 167–169.
  110. Ruckenstein M.J., Harrison R.V. Cochlear pathology in Ménière’s disease // Ménière’s Disease / ed. J.P. Harris. Hague : Kugler Publications, 1999. P. 195–202.
  111. Russo F.Y., Nguyen Y., De Seta D. et al. Meniett device in Ménière’s disease: randomized, double-blind, placebo-controlled multicenter trial // Laryngoscope. 2017. Vol. 127, N 2. P. 470–475.
  112. Ruth R., Lambert P. Comparison of tympanic membrane to promontory electrode recordings of electrocochleographic responses in patients with Ménière’s disease // Otolaryngol. Head Neck Surg. 1989. Vol. 100. P. 546–552.
  113. Ryu H., Yamamoto S., Sugiyama K., Nozue M. Neurovascular compression syndrome of the eighth cranial nerve. What are the most reliable diagnostic signs? // Acta Neurochir. (Wien). 1998. Vol. 140, N 12. P. 1279–1286.
  114. Saeed S.R. Fortnightly review: diagnosis and treatment of Ménière’s disease // BMJ. 1998. Vol. 316. P. 368–372.
  115. Salami A., Dellepiane M., Tinelle E. et al. Double blind study between betahistine hydrochloride and placebo in the treatment of Ménière’s syndromes // Valsalva. 1984. Vol. 60. P. 302–312.
  116. Schuknecht H.F. Cupulolithiasis // Arch. Otolaryngol. 1969. Vol. 90, N 6. P. 765–778.
  117. Heidenreich K.D., Kerber K.A., Carender W.J. et al. Persistent positional nystagmus: a case of superior semicircular canal benign paroxysmal positional vertigo? // Laryngoscope. 2011. Vol. 121. P. 1818–1820.
  118. Semont A. Vertige au changement de position, 16/12/2007. URL: http://www.vestib.org/chap.5vertigesetpath./pathovcp.html
  119. Sevilla C., Goody J., Baguley D.M., Kasbekar A.V. Aural fullness and transtympanic ventilation tubes in Ménière’s disease: a scoping review // J. Laryngol. Otol. 2019. Vol. 133, N 6. P. 450–456.
  120. Silverstein H., Smouha E., Jones R. Natural history versus surgery for Ménière’s disease // Otolaryngol. Head Neck Surg. 1989. Vol. 100. P. 6–16.
  121. Sirikci A., Bayazit Y., Ozer E., Ozkur A., Adaletli I., Cüce M.A. et al. Magnetic resonance imaging based classification of anatomic relationship between the cochleovestibular nerveand anterior inferior cerebellar artery in patients with non-specific neuro-otologic symptoms // Surg. Radiol. Anat. 2005. Vol. 27, N 6. P. 531–535.
  122. Stokroos R., Kingma H. Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Ménière’s disease: a prospective, double-blind, placebo-controlled, randomized clinical trial // Acta Otolaryngol. 2004. Vol. 124. P. 172–175.
  123. Storper I.S., Spitzer J.B., Scanlan M. Use of glycopyrrolate in the treatment of Ménière’s disease // Laryngoscope. 1998. Vol. 108. P. 1442–1445.
  124. Strupp M., Huppert D., Frenzel C. et al. Long-term prophylactic treatment of attacks of vertigo in Ménière’s disease — comparison of a high with a low dosage of betahistine in an open trial // Acta Otolaryngol. 2008. Vol. 128. P. 520–524.
  125. Strupp M., Arbusow V., Maag K.P., Gall C., Brandt T. Vestibular exercises improve central vestibulospinal compensation after vestibular neuritis // Neurology. 1998. Vol. 51, N 3. P. 838–844.
  126. Brandt T., Zwergal A., Jahn K., Strupp M. Integrated center for research and treatment of vertigo, balance and ocular motor disorders // Nervenarzt. 2009. Vol. 80. P. 875–886.
  127. Strupp M., Brandt T. Diagnosis and treatment of vertigo and dizziness // Dtsch. Arztebl. Int. 2008. Vol. 105, N 10. P. 173–180.
  128. Strupp M., Dieterich M., Brandt T. The treatment and natural course of peripheral and central vertigo // Dtsch. Arztebl. Int. 2013. Vol. 110, N 29–30. P. 505–516.
  129. Szmulewicz D.J., Waterston J.A., Halmagyi G.M., Mossman S., Chancellor A.M., McLean C.A. et al. Sensory neuropathy as part of the cerebellar ataxia neuropathy vestibular areflexia syndrome // Neurology. 2011. Vol. 76, N 22. P. 1903–1910.
  130. Von Brevern M., Seelig T., Neuhauser H., Lempert T. Benign paroxysmal positional vertigo predominantly affects the right labyrinth // J. Neurol. Neurosurg. Psychiatry. 2004. Vol. 75, N 10. P. 1487–1488.
  131. Theil D., Derfuss T., Strupp M., Gilden D.H., Arbusow V., Brandt T. Cranial nerve palsies: herpes simplex virus type 1 and varizella-zoster virus latency // Ann. Neurol. 2002. Vol. 51, N 2. P. 273–274.
  132. Thomsen J., Bonding P., Becker B. et al. The non-specific effect of endolymphatic sac surgery in treatment of Ménière’s disease: a prospective, randomized controlled study comparing «classic» endolymphatic sac surgery with the insertion of a ventilating tube in the tympanic membrane // Acta Otolaryngol. 1998. Vol. 118. P. 769–773.
  133. Yamakawa K. Über die pathologische Veranderung bei einem Ménière’s-Kranken. Proceedings of the 42nd Annual Meeting Oto-Rhino-Laryngological Society of Japan // J. Otolaryngol. Soc. Jpn. 1938. Vol. 4. P. 2310–2312.
  134. Wei D., Hain T.C., Proctor L. Head-shaking nystagmus: associations with canal paresis and hearing loss // Acta Otolaryngol. 1989. Vol. 108. P. 362–367.
  135. Wright T. Ménière’s disease // BMJ Clin. Evid. 2006. Vol. 2006. Article ID 0505.
  136. Zou J., Pyykko I., Bjelke B. et al. Communication between the perilymphatic scalae and spiral ligament visualized by in vivo MRI // Audiol. Neurootol. 2005. Vol. 10, N 3. P. 145–152.
  137. Saber Tehrani A.S., Kattah J.C., Kerber K.A., Gold D.R., Zee D.S., Urrutia V.C. et al. Diagnosing stroke in acute dizziness and vertigo: pitfalls and pearls // Stroke. 2018. Vol. 49, N 3. P. 788–795. DOI: https://doi.org/10.1161/STROKEAHA.117.016979 Epub 2018 Feb 19. PMID: 29459396; PMCID: PMC5829023.
  138. Chalela J.A., Kidwell C.S., Nentwich L.M. et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison // Lancet. 2007. Vol. 369, N 9558. P. 293–298.
  139. Straube A., Buttner U. and Brandt T., Recurrent attacks with skew deviation, torsional nystagmus, and contraction of the left frontalis muscle // Neurology. 1994. Vol. 44. P. 177–178.
  140. Strupp M., Lopez-Escamez J.A., Kim J.S., Straumann D., Jen J.C., Carey J. et al. Vestibular paroxysmia: diagnostic criteria // J. Vestib. Res. 2016. Vol. 26, N 5–6. P. 409–415. DOI: https://doi.org/10.3233/VES-160589 PMID: 28262641.
  141. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. 3rd ed. // Cephalalgia. 2018. Vol. 38, N 1. P. 1–211.

Для продолжения работы требуется вход / регистрация